-+ 0.00%
-+ 0.00%
-+ 0.00%

ADAGENE ANNOUNCES NMPA CLEARANCE OF INVESTIGATIONAL NEW DRUG APPLICATION FOR ADG138, A NOVEL HER2XCD3 DOUBLE-MASKED BISPECIFIC T-CELL ENGAGER

Reuters·09/22/2026 12:00:01

Please log in to view news